[{"Assets_0_Q3_USD":110415000.0,"CommonStockSharesOutstanding_0_Q3_shares":16944103.0,"NetIncomeLoss_1_Q3_USD":-4825000.0,"NetIncomeLoss_3_Q3_USD":-33905000.0,"StockholdersEquity_0_Q3_USD":57836000.0,"Ticker":"PTGX","CIK":"1377121","name":"PROTAGONIST THERAPEUTICS, INC","OfficialName":"Protagonist Therapeutics Inc. Common Stock","form":"10-Q","period":"20170930","fy":"2017.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"939483174.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20171107"}]